USH2A and Patent foramen ovale: This study first reveals genetic characteristics of Tibetan PFO patients, implicating GABRP, GJB4, RTTN, and USH2A mutations in disrupting cardiac developmental pathways, potentially contributing to the occurrence of PFO.